SCHEMBL8046979

SCHEMBL8046979

C=C1CCC(C)C(=O)N(C[C@@H](NC(=O)N[C@H]2CCCCCCCCC[C@@H](C(=O)C(=O)NC3CC3)NC(=O)[C@@H]3[C@@H]4[C@H](CN3C2=O)C4(C)C)C(C)(C)C)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8053405 0.92 — —
SCHEMBL8046972 0.90 — —
SCHEMBL12607463 0.87 — —
SCHEMBL7857573 0.86 — —
SCHEMBL8056194 0.86 — —
SCHEMBL12608446 0.86 — —
SCHEMBL12607184 0.86 — —
SCHEMBL12607464 0.86 — —
SCHEMBL12608342 0.86 — —
SCHEMBL8038618 0.86 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009058856-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS NS3 SERINE PROTEASE SCHERING CORPORATION (US) 2009-05-07 — — WO disclosed
Send feedback